Literature DB >> 11474709

In vitro activities of mitomycin C against growing and hypoxic dormant tubercle bacilli.

H L Peh, A Toh, B Murugasu-Oei, T Dick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11474709      PMCID： PMC90667          DOI： 10.1128/AAC.45.8.2403-2404.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  8 in total

1.  Dormant tubercle bacilli: the key to more effective TB chemotherapy?

Authors:  T Dick
Journal:  J Antimicrob Chemother       Date:  2001-01       Impact factor: 5.790

Review 2.  Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting.

Authors:  Y C Manabe; W R Bishai
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

3.  An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence.

Authors:  L G Wayne; L G Hayes
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  Bactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG.

Authors:  B Murugasu-Oei; T Dick
Journal:  J Antimicrob Chemother       Date:  2000-12       Impact factor: 5.790

5.  A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis.

Authors:  C K Stover; P Warrener; D R VanDevanter; D R Sherman; T M Arain; M H Langhorne; S W Anderson; J A Towell; Y Yuan; D N McMurray; B N Kreiswirth; C E Barry; W R Baker
Journal:  Nature       Date:  2000-06-22       Impact factor: 49.962

6.  Oxygen depletion-induced dormancy in Mycobacterium bovis BCG.

Authors:  A Lim; M Eleuterio; B Hutter; B Murugasu-Oei; T Dick
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

Review 7.  The mitomycin bioreductive antitumor agents: cross-linking and alkylation of DNA as the molecular basis of their activity.

Authors:  M Tomasz; Y Palom
Journal:  Pharmacol Ther       Date:  1997 Oct-Dec       Impact factor: 12.310

8.  Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis.

Authors:  L G Wayne; H A Sramek
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191
  8 in total
  6 in total

1.  Mycobacterium bovis BCG response regulator essential for hypoxic dormancy.

Authors:  Calvin Boon; Thomas Dick
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

Review 2.  Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy.

Authors:  Digby F Warner; Valerie Mizrahi
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

3.  Role of stress response sigma factor SigG in Mycobacterium tuberculosis.

Authors:  Jong-Hee Lee; Deborah E Geiman; William R Bishai
Journal:  J Bacteriol       Date:  2007-11-26       Impact factor: 3.490

4.  Biological Profiling Enables Rapid Mechanistic Classification of Phenotypic Screening Hits and Identification of KatG Activation-Dependent Pyridine Carboxamide Prodrugs With Activity Against Mycobacterium tuberculosis.

Authors:  Melissa D Chengalroyen; Audrey Jordaan; Ronnett Seldon; Thomas Ioerger; Scott G Franzblau; Mohamed Nasr; Digby F Warner; Valerie Mizrahi
Journal:  Front Cell Infect Microbiol       Date:  2020-11-13       Impact factor: 5.293

5.  Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program.

Authors:  Martin I Voskuil; Dirk Schnappinger; Kevin C Visconti; Maria I Harrell; Gregory M Dolganov; David R Sherman; Gary K Schoolnik
Journal:  J Exp Med       Date:  2003-09-01       Impact factor: 14.307

6.  The enduring hypoxic response of Mycobacterium tuberculosis.

Authors:  Tige R Rustad; Maria I Harrell; Reiling Liao; David R Sherman
Journal:  PLoS One       Date:  2008-01-30       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.